Skip to main content

Galectin Therapeutics Inc DEF 14A, filed Oct 13, 2026

Galectin Therapeutics Inc (GALT)

DEF 14A 2026-10-13 For: 2026-12-03
View Original
Added on October 13, 2026

About this DEF 14A

Galectin Therapeutics Inc filed this DEF 14A on October 13, 2026.

Galectin Therapeutics will ask stockholders on December 3, 2026 to elect eleven directors, increase authorized common shares from 150,000,000 to 250,000,000, reserve 3,000,000 additional shares under its 2019 Omnibus Equity Incentive Plan, and ratify Cherry Bekaert LLP as auditor. AI summary